Comerica Bank’s Vor Biopharma VOR Stock Holding History

Comerica Bank’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-133	Closed	-$6.31K	–	3818
2024 Q1	$6.31K	Buy	+133	New	+$5.84K	﹤0.01%	3283

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's VOR Position: Q2 2024 in Review

Comerica Bank sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 133 shares — an estimated $6.31K sold.

Comerica Bank first reported a position in VOR in Q1 2024 and held it in 1 quarter. The position peaked at $6.31K in Q1 2024. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

Comerica Bank reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
Comerica Bank sold 133 Vor Biopharma shares in Q2 2024, an estimated $6.31K.
Comerica Bank first reported a position in Vor Biopharma in Q1 2024 and held it in 1 quarter.
Comerica Bank's Vor Biopharma position peaked at $6.31K in Q1 2024.
71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Comerica Bank's 13F filing for Q2 2024, filed 15 Aug 2024.